Search research articles
Contact Us
Filters
Showing results (191-200 of 473) with videos related to
Page
of 48
Sort By:
Anti-Cancer Drugs
|
February 3, 2011
Novel modalities in the treatment of patients with KRAS-mutated colorectal cancer
Anastasios Dimou, Konstantinos Syrigos, Muhammad Wasif Saif
Discovery Medicine
|
June 30, 2016
New concepts in the treatment strategy of neuroendocrine tumors: the role of biotherapy
George Papaxoinis, Kostas Syrigos, Muhammad Wasif Saif
JOP : Journal of the Pancreas
|
March 13, 2014
Novel treatment approaches for locally advanced pancreatic cancer
Daniel Gorovets, Muhammad Wasif Saif, Kathryn Huber
JOP : Journal of the Pancreas
|
March 13, 2014
Updates on first-line therapy for metastatic pancreatic adenocarcinoma
Eric Marks, Muhammad Wasif Saif, Yuxia Jia
Clinical Colorectal Cancer
|
October 10, 2006
Hand-foot syndrome variant in a dihydropyrimidine dehydrogenase-deficient patient treated with capecitabine
Muhammad Wasif Saif, Aymen Elfiky, Robert Diasio
JOP : Journal of the Pancreas
|
July 31, 2014
Thromboembolism and pancreatic cancer
Andre Luiz De Souza, Muhammad Wasif Saif
JOP : Journal of the Pancreas
|
July 31, 2014
Pancreatic cancer: new hopes for early detection and a future screening tool?
Najla H El-Jurdi, Muhammad Wasif Saif
Cutaneous and Ocular Toxicology
|
September 12, 2013
Topical henna ameliorated capecitabine-induced hand-foot syndrome
Saher Ilyas, Komal Wasif, Muhammad Wasif Saif
Expert Opinion on Investigational Drugs
|
January 8, 2026
An overview of KRAS-targeting therapies for colorectal cancer in phase I and II development
Shadi Chamseddine, Asfar Azmi, Muhammad Wasif Saif
World Journal of Gastrointestinal Oncology
|
October 21, 2015
Targeted therapies for pancreatic adenocarcinoma: Where do we stand, how far can we go?
Dimitra Grapsa, Muhammad Wasif Saif, Konstantinos Syrigos
Page
of 48
Search research articles
Search
Showing results (191-200 of 473) with videos related to
Sort By:
Page
of 48
Anti-Cancer Drugs
|
February 3, 2011
Novel modalities in the treatment of patients with KRAS-mutated colorectal cancer
Anastasios Dimou, Konstantinos Syrigos, Muhammad Wasif Saif
Discovery Medicine
|
June 30, 2016
New concepts in the treatment strategy of neuroendocrine tumors: the role of biotherapy
George Papaxoinis, Kostas Syrigos, Muhammad Wasif Saif
JOP : Journal of the Pancreas
|
March 13, 2014
Novel treatment approaches for locally advanced pancreatic cancer
Daniel Gorovets, Muhammad Wasif Saif, Kathryn Huber
JOP : Journal of the Pancreas
|
March 13, 2014
Updates on first-line therapy for metastatic pancreatic adenocarcinoma
Eric Marks, Muhammad Wasif Saif, Yuxia Jia
Clinical Colorectal Cancer
|
October 10, 2006
Hand-foot syndrome variant in a dihydropyrimidine dehydrogenase-deficient patient treated with capecitabine
Muhammad Wasif Saif, Aymen Elfiky, Robert Diasio
JOP : Journal of the Pancreas
|
July 31, 2014
Thromboembolism and pancreatic cancer
Andre Luiz De Souza, Muhammad Wasif Saif
JOP : Journal of the Pancreas
|
July 31, 2014
Pancreatic cancer: new hopes for early detection and a future screening tool?
Najla H El-Jurdi, Muhammad Wasif Saif
Cutaneous and Ocular Toxicology
|
September 12, 2013
Topical henna ameliorated capecitabine-induced hand-foot syndrome
Saher Ilyas, Komal Wasif, Muhammad Wasif Saif
Expert Opinion on Investigational Drugs
|
January 8, 2026
An overview of KRAS-targeting therapies for colorectal cancer in phase I and II development
Shadi Chamseddine, Asfar Azmi, Muhammad Wasif Saif
World Journal of Gastrointestinal Oncology
|
October 21, 2015
Targeted therapies for pancreatic adenocarcinoma: Where do we stand, how far can we go?
Dimitra Grapsa, Muhammad Wasif Saif, Konstantinos Syrigos
Page
of 48